Robert Nisticò Selected Research

M40401

10/2004	The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of the lectin-like oxidized low-density lipoprotein receptor-1.
6/2003	The protective effect of M40401, a superoxide dismutase mimetic, on post-ischemic brain damage in Mongolian gerbils.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Nisticò Research Topics

Disease

28	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 01/2011
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 12/2013
6	Cognitive Dysfunction 01/2022 - 01/2013
6	Mental Disorders (Mental Disorder) 11/2021 - 01/2009
4	Schizophrenia (Dementia Praecox) 01/2016 - 01/2009
3	Neuroinflammatory Diseases 01/2021 - 01/2020
3	Brain Ischemia (Cerebral Ischemia) 01/2019 - 01/2007
3	Multiple Sclerosis 01/2017 - 06/2014
3	Dementia (Dementias) 01/2017 - 04/2014
3	Ischemia 02/2010 - 06/2003
2	Inflammation (Inflammations) 03/2021 - 10/2016
2	Brain Diseases (Brain Disorder) 01/2021 - 02/2010
2	Stroke (Strokes) 01/2017 - 01/2009
2	Nervous System Diseases (Neurological Disorders) 01/2017 - 12/2015
2	Parkinson Disease (Parkinson's Disease) 06/2016 - 11/2014
2	Opioid-Related Disorders (Opiate Addiction) 01/2016 - 01/2015
2	Dyskinesias (Dyskinesia) 11/2014 - 09/2013
2	Clinical Deterioration 06/2014 - 12/2013
1	Neurobehavioral Manifestations 01/2022
1	Autism Spectrum Disorder 11/2021
1	Fabry Disease (Fabry's Disease) 10/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2019
1	Epilepsy (Aura) 01/2019
1	Tauopathies 01/2019
1	Amyloid Plaque 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2017
1	Metabolic Diseases (Metabolic Disease) 01/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2015
1	Catalepsy 07/2015
1	Pain (Aches) 01/2015
1	Body Weight (Weight, Body) 01/2015
1	Cardiac Arrhythmias (Arrythmia) 01/2015

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2002
5	Amyloid (Amyloid Fibrils)IBA 11/2021 - 01/2011
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2014
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2015
4	Biological ProductsIBA 11/2021 - 01/2018
4	EnzymesIBA 11/2021 - 02/2012
4	Nerve Growth Factor (NGF)IBA 01/2021 - 01/2016
3	Neuroprotective AgentsIBA 01/2021 - 01/2007
3	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 08/2010
3	Amyloid beta-PeptidesIBA 01/2017 - 01/2015
3	Superoxide DismutaseIBA 06/2012 - 06/2003
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2021 - 01/2011
2	NeurograninIBA 01/2021 - 01/2017
2	Lithium ChlorideIBA 01/2019 - 02/2002
2	Glutamic Acid (Glutamate)FDA Link 01/2019 - 12/2015
2	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2017 - 02/2012
2	Phosphotransferases (Kinase)IBA 06/2016 - 09/2013
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 12/2015 - 11/2014
2	Levodopa (L Dopa)FDA LinkGeneric 11/2014 - 09/2013
2	Platelet-Derived Growth FactorIBA 06/2014 - 12/2013
2	Glucose (Dextrose)FDA LinkGeneric 02/2010 - 01/2007
2	Oxygen (Dioxygen)IBA 02/2010 - 01/2007
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2009 - 01/2008
2	M40401IBA 10/2004 - 06/2003
2	Malondialdehyde (Propanedial)IBA 10/2004 - 06/2003
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2022
1	NeuregulinsIBA 11/2021
1	GalactosidasesIBA 10/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2021
1	SynucleinsIBA 01/2021
1	Acid Sensing Ion Channel BlockersIBA 01/2021
1	aducanumabIBA 01/2021
1	Synaptotagmins (Synaptotagmin)IBA 01/2021
1	Acid Sensing Ion ChannelsIBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	Serine (L-Serine)FDA Link 12/2020
1	LigandsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 10/2019
1	N- (4- (2- methoxyphenoxy)phenyl)- N- (2,2,2- trifluoroethylsulfonyl)pyrid- 3- ylmethylamineIBA 01/2019
1	LithiumIBA 01/2019
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Caveolin 1IBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	AdiponectinIBA 01/2017
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	Chemokine CCL5IBA 10/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2016
1	Ginkgo biloba extract (Rokan)IBA 01/2016
1	Hydrocodone (Dihydrocodeinone)FDA LinkGeneric 01/2016
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2016
1	Tryptophan (L-Tryptophan)FDA Link 12/2015
1	Antipsychotic Agents (Antipsychotics)IBA 12/2015
1	KynurenineIBA 12/2015
1	xanthurenic acidIBA 12/2015
1	Excitatory Amino AcidsIBA 12/2015
1	Haloperidol (Haldol)FDA LinkGeneric 07/2015
1	Caffeine (No Doz)FDA LinkGeneric 07/2015
1	Opioid Analgesics (Opioids)IBA 01/2015
1	Methadone (Dolophine)FDA LinkGeneric 01/2015

Therapy/Procedure

11	Therapeutics 01/2022 - 06/2012
3	Precision Medicine 01/2021 - 01/2018
1	Transcranial Magnetic Stimulation 03/2019
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2017